APM
Aptorum Group LimitedNASDAQHealthcare$0.89-4.33%ClosedMarket Cap: $5.6M
As of 2026-04-07
Valuation
P/E (TTM)
—
PEG
—
P/B
0.28
P/S
0.00
EV/EBITDA
-3.13
DCF Value
$-0.01
FCF Yield
1.6%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-5.9%
ROA
-7.3%
ROIC
-10.3%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $0.00 | NaN% | $-1.4M | $-921.5K | $-0.13 | — |
| FY 2025 | $0.00 | NaN% | $-1.8M | $-1.4M | $-0.19 | — |
| Q2 2025 | $0.00 | NaN% | $-402.8K | $-441.8K | $-0.06 | — |
| Q4 2024 | $0.00 | NaN% | $-1.1M | $-1.6M | $-0.29 | — |
| FY 2024 | $0.00 | -Infinity% | $-3.8M | $-4.3M | $-0.78 | — |
| Q2 2024 | $0.00 | -Infinity% | $-2.9M | $-2.6M | $-0.50 | — |
| Q4 2023 | $0.00 | -Infinity% | $-4.0M | $2.7M | $0.51 | — |
| FY 2023 | $431.4K | 2.4% | $-10.6M | $-2.8M | $-0.62 | — |
| Q2 2023 | $431.4K | -154.2% | $-6.5M | $-5.5M | $-1.43 | — |
| Q4 2022 | $768.4K | -70.5% | $-9.1M | $-7.9M | $-2.22 | — |
| FY 2022 | $1.3M | 6.2% | $-17.5M | $-9.8M | $-2.75 | — |
| Q2 2022 | $527.5K | -110.9% | $-8.5M | $-1.9M | $-0.53 | — |